Diabeloop: Launch of a Multi-Country Clinical Study in Adolescents and Young Adults With T1D
Retrieved on:
Thursday, February 23, 2023
Diabetes, Automated insulin delivery system, Prince Sultan Advanced Technology Research Institute, Treatment, CEA-Leti: Laboratoire d'électronique des technologies de l'information, International Conference on Availability, Reliability and Security, T1D, Patient, Trial of the century, Necker–Enfants Malades Hospital, Conference, Nutrition, German Diabetes Center Mergentheim, Social environment, Glycated hemoglobin, Ageing, Pharmaceutical industry, Dietary supplement, Birth control
BERLIN, Feb. 23, 2023 (GLOBE NEWSWIRE) -- At the International Conference on Advanced Technologies & Treatments for Diabetes, Diabeloop, a leader in Automated Insulin Delivery technology, announces the launch of a clinical study in adolescents and young adults with T1D, in France, Belgium and Germany.
Key Points:
- BERLIN, Feb. 23, 2023 (GLOBE NEWSWIRE) -- At the International Conference on Advanced Technologies & Treatments for Diabetes, Diabeloop, a leader in Automated Insulin Delivery technology, announces the launch of a clinical study in adolescents and young adults with T1D, in France, Belgium and Germany.
- The wearable, lightweight patch pump will optimize comfort for the 50 adolescents and young adults with T1D, aged from 12 to 18 years old, enrolled in this study.
- Nevertheless, for many adolescents, it remains a burden to enter carb counts even during automated insulin therapy.
- We are eager to study new approaches to reduce this burden in our clinical research center like this international collaborative study in adolescents and young adults," declares Prof. Thomas Danne.